HIMS Hims & Hers Health, Inc.
USHealthcareAs of 2026-07-10 16:00
Why HIMS matters now
Hims & Hers Health, Inc. (HIMS) is a US stock in Healthcare. The latest InvestLog snapshot shows $34.38 with -3.02% on the session and $7.67B in market capitalization; recent performance reads 1-month +58.07% and YTD +9.24%.
The latest financial table shown here is Q1 2026, with revenue of $608.1M, net income of $-92.1M, and EPS of $-0.40. Investors can compare that operating picture with valuation signals such as P/E 33.23 and FCF yield 1.0%.
The latest indexable market news headline is "Hims & Hers Health: The Market Still Doesn't Get It" from Seeking Alpha.
Additional event context on this page matters because analyst consensus is Hold with a median target of $25.00; recent insider activity includes Elshenawy Mohamed filing S-Sale. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
33.23
PEG
18.00
P/B
18.15
P/S
3.34
EV/EBITDA
293.52
DCF Value
$107.80
FCF Yield
1.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
67.6%
Operating Margin
1.3%
Net Margin
-0.6%
ROE
-2.5%
ROA
-0.6%
ROIC
0.7%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $608.1M | $-92.1M | $-0.40 |
| Q4 2025 | $617.8M | $20.6M | $0.08 |
| FY 2025 | $2.35B | $128.4M | $0.51 |
| Q3 2025 | $599.0M | $15.8M | $0.06 |
Analyst Ratings
Consensus
Hold
Target (Consensus)
$28.08
Target (Median)
$25.00
Target Range
$12.50 - $60.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Equipment & Services
Country
US
Exchange
—
Beta
2.40
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.